Advertisement
Screener

Oyster Point Pharma, Inc. General and Administrative Expense

Oyster Point Pharma, Inc. General and Administrative Expense

Oyster Point Pharma, Inc. reported General and Administrative Expense of $12.15 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:GeneralAndAdministrativeExpense · last filed 2022-11-10

  • Oyster Point Pharma, Inc. general and administrative expense for the quarter ending 2022-09-30 was $12.15M, a 17.64% increase year-over-year.
  • Oyster Point Pharma, Inc. general and administrative expense for the quarter ending 2022-06-30 was $14.00M, a 54.13% increase year-over-year.
  • Oyster Point Pharma, Inc. general and administrative expense for the quarter ending 2022-03-31 was $12.93M, a 51.70% increase year-over-year.
  • Oyster Point Pharma, Inc. general and administrative expense for the quarter ending 2021-12-31 was $12.88M, a 22.19% increase year-over-year.
  • Oyster Point Pharma, Inc. general and administrative expense for fiscal 2021 was $40.81M, a 91.57% increase from fiscal 2020.
  • Oyster Point Pharma, Inc. general and administrative expense for fiscal 2020 was $21.30M, a 55.82% increase from fiscal 2019.
  • Oyster Point Pharma, Inc. general and administrative expense for fiscal 2019 was $13.67M, a 358.67% increase from fiscal 2018.
  • Oyster Point Pharma, Inc. general and administrative expense for fiscal 2018 was $2.98M.
Period endGeneral and Administrative Expense 3 monthGeneral and Administrative Expense 3 month as first filedGeneral and Administrative Expense 6 monthGeneral and Administrative Expense 6 month as first filedGeneral and Administrative Expense 9 monthGeneral and Administrative Expense 9 month as first filedGeneral and Administrative Expense 12 monthGeneral and Administrative Expense 12 month as first filed
2022-09-30$12.15M
10-Q · filed 2022-11-10
$26.15M
derived: sum of 2 quarters · filed 2022-11-10
$39.08M
10-Q · filed 2022-11-10
$51.96M
derived: sum of 4 quarters · filed 2022-11-10
2022-06-30$14.00M
10-Q · filed 2022-08-11
$26.93M
10-Q · filed 2022-08-11
$39.81M
derived: sum of 3 quarters · filed 2022-08-11
$50.14M
derived: sum of 4 quarters · filed 2022-11-10
2022-03-31$12.93M
10-Q · filed 2022-05-05
$25.81M
derived: sum of 2 quarters · filed 2022-05-05
$36.13M
derived: sum of 3 quarters · filed 2022-11-10
$45.22M
derived: sum of 4 quarters · filed 2022-11-10
2021-12-31$12.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$23.20M
derived: sum of 2 quarters · filed 2022-11-10
$32.29M
derived: sum of 3 quarters · filed 2022-11-10
$40.81M
10-K · filed 2022-02-24
2021-09-30$10.33M
10-Q · filed 2022-11-10
$28.50M
10-Q · filed 2021-11-04
$19.41M
derived: sum of 2 quarters · filed 2022-11-10
$27.94M
10-Q · filed 2022-11-10
$56.88M
10-Q · filed 2021-11-04
$38.48M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$9.09M
10-Q · filed 2022-08-11
$15.30M
10-Q · filed 2021-08-05
$17.61M
10-Q · filed 2022-08-11
$28.39M
10-Q · filed 2021-08-05
$28.15M
derived: sum of 3 quarters · filed 2022-08-11
$36.26M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$8.53M
10-Q · filed 2022-05-05
$13.09M
10-Q · filed 2021-05-06
$19.06M
derived: sum of 2 quarters · filed 2022-05-05
$27.17M
derived: sum of 3 quarters · filed 2022-05-05
$34.11M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$10.54M
10-K · filed 2021-02-18
$18.65M
derived: sum of 2 quarters · filed 2021-11-04
$25.59M
derived: sum of 3 quarters · filed 2021-11-04
$21.30M
10-K · filed 2022-02-24
$31.18M
10-K · filed 2021-02-18
2020-09-30$8.11M
10-Q · filed 2021-11-04
$15.05M
derived: sum of 2 quarters · filed 2021-11-04
$20.64M
10-Q · filed 2021-11-04
$25.77M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$6.94M
10-Q · filed 2021-08-05
$12.53M
10-Q · filed 2021-08-05
$17.66M
derived: sum of 3 quarters · filed 2021-08-05
$21.46M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$5.59M
10-Q · filed 2021-05-06
$10.72M
derived: sum of 2 quarters · filed 2021-05-06
$14.53M
derived: sum of 3 quarters · filed 2021-05-06
$17.66M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$5.13M
10-K · filed 2021-02-18
$8.94M
derived: sum of 2 quarters · filed 2021-02-18
$12.07M
derived: sum of 3 quarters · filed 2021-02-18
$13.67M
10-K · filed 2021-02-18
2019-09-30$3.81M
10-K · filed 2021-02-18
$6.94M
derived: sum of 2 quarters · filed 2021-02-18
$8.55M
10-Q · filed 2020-11-05
$9.25M
derived: sum of 4 quarters · filed 2021-02-18
2019-06-30$3.13M
10-K · filed 2021-02-18
$4.74M
10-Q · filed 2020-08-05
$5.44M
derived: sum of 3 quarters · filed 2021-02-18
$6.36M
derived: sum of 4 quarters · filed 2021-02-18
2019-03-31$1.60M
10-K · filed 2021-02-18
$2.31M
derived: sum of 2 quarters · filed 2021-02-18
$3.23M
derived: sum of 3 quarters · filed 2021-02-18
$3.96M
derived: sum of 4 quarters · filed 2021-02-18
2018-12-31$704.00K
10-K · filed 2020-02-27
$1.62M
derived: sum of 2 quarters · filed 2020-02-27
$2.35M
derived: sum of 3 quarters · filed 2020-02-27
$2.98M
10-K · filed 2020-02-27
2018-09-30$916.00K
10-K · filed 2020-02-27
$1.65M
derived: sum of 2 quarters · filed 2020-02-27
$2.28M
10-Q · filed 2019-12-03
2018-06-30$735.00K
10-K · filed 2020-02-27
$1.36M
derived: sum of 2 quarters · filed 2020-02-27
2018-03-31$626.00K
10-K · filed 2020-02-27